Krasavage W J
Drug Chem Toxicol. 1984;7(4):329-34. doi: 10.3109/01480548408998261.
The potential for tertiary butylhydroquinone (TBHQ) to produce hemorrhagic death similar to that seen after butylated hydroxytoluene (BHT) treatment was tested in male rats. Groups of male rats were given three consecutive daily doses of 380, 760 or 1520 mg/kg/day BHT or 50, 100 or 150 mg/kg TBHQ. Twenty-four hours following the last dose, the rats were killed, blood was taken for prothrombin determinations and gross autopsies were performed. No evidence of hemorrhage was found in any of the animals. BHT caused a significant dose-dependent increase in prothrombin times, while the prothrombin times of the TBHQ rats were comparable to the controls. Since hypoprothrombinemia plays a major role in producing hemorrhagic death, these data indicate that the potential for THBQ to have such an effect is low.
在雄性大鼠中测试了叔丁基对苯二酚(TBHQ)产生与丁基化羟基甲苯(BHT)处理后所见类似的出血性死亡的可能性。将雄性大鼠分组,连续三天每日给予380、760或1520毫克/千克/天的BHT或50、100或150毫克/千克的TBHQ。最后一次给药24小时后,处死大鼠,采集血液测定凝血酶原,并进行大体尸检。在任何动物中均未发现出血迹象。BHT导致凝血酶原时间显著呈剂量依赖性增加,而TBHQ组大鼠的凝血酶原时间与对照组相当。由于低凝血酶原血症在导致出血性死亡中起主要作用,这些数据表明TBHQ产生这种作用的可能性较低。